We are live on ! Find out more
VC

Vivo Capital Portfolio holdings

AUM $1.2B
1-Year Est. Return 911.44%
This Fund
S&P 500
This Quarter Est. Return
-5.19%
1 Year Est. Return
+911.44%
3 Year Est. Return
+7,373.93%
5 Year Est. Return
+10,475.15%
10 Year Est. Return
+136,503.27%
AUM
$1.1B
AUM Growth
-$269M
Cap. Flow
-$108M
Cap. Flow %
-9.78%
Top 10 Hldgs %
61.03%
Holding
57
New
53
Increased
–
Reduced
–
Closed
4

Top Buys

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$260M
2
NFH
New Frontier Health Corporation Ordinary Shares
NFH
+$130M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$68.1M
4
KDMN
Kadmon Holdings, Inc.
KDMN
+$54M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$45.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 87.06%
2 Financials 10.69%
3 Materials 1.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCKT icon
26
Rocket Pharmaceuticals
RCKT
$387M
$12M 1.09%
+860,648
New +$17M
KNSA icon
27
Kiniksa Pharmaceuticals
KNSA
$5.97B
$11.8M 1.06%
+759,050
New +$11.9M
TCDA
28
DELISTED
Tricida, Inc. Common Stock
TCDA
$11.5M 1.04%
+524,290
New +$16.8M
ZLAB icon
29
Zai Lab
ZLAB
$2.36B
$11.4M 1.04%
+222,107
New +$11.6M
KALV
30
DELISTED
KalVista Pharmaceuticals
KALV
$11.3M 1.02%
+1,476,796
New +$19.9M
IGMS
31
DELISTED
IGM Biosciences
IGMS
$11.2M 1.02%
+199,626
New +$8.75M
TECX
32
Tectonic Therapeutic
TECX
$570M
$11.2M 1.01%
+59,813
New +$14.1M
YARW
33
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$10.3M 0.93%
+1,068
New +$16.8M
TRIL
34
DELISTED
Trillium Therapeutics Inc.
TRIL
$8.3M 0.75%
+2,054,468
New +$7.77M
COLL icon
35
Collegium Pharmaceutical
COLL
$944M
$7.3M 0.66%
+447,173
New +$9.23M
AUPH icon
36
Aurinia Pharmaceuticals
AUPH
$2.07B
$7.27M 0.66%
+500,732
New +$8.83M
KALA icon
37
KALA BIO
KALA
$14.2M
$6.92M 0.63%
+315
New +$5.03M
MTNB icon
38
Matinas BioPharma
MTNB
$1.72M
$6.77M 0.61%
+225,586
New +$13.6M
BDTX icon
39
Black Diamond Therapeutics
BDTX
$110M
$6.29M 0.57%
+252,119
New +$7.67M
VRNA
40
DELISTED
Verona Pharma
VRNA
$6.15M 0.56%
+1,492,951
New +$8.19M
SLNO
41
DELISTED
Soleno Therapeutics
SLNO
$4.81M 0.44%
+134,758
New +$5.73M
CHMA
42
DELISTED
Chiasma, Inc. Common Stock
CHMA
$4.64M 0.42%
+1,272,156
New +$5.64M
XENE icon
43
Xenon Pharmaceuticals
XENE
$6.24B
$4.5M 0.41%
+396,589
New +$5.65M
CNST
44
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$4.41M 0.4%
+140,298
New +$4.88M
RVMD icon
45
Revolution Medicines
RVMD
$42.1B
$4.37M 0.4%
+199,518
New +$5.52M
GLMD icon
46
Galmed Pharmaceuticals
GLMD
$4.95M
$2.98M 0.27%
+4,778
New +$4.54M
ATRC icon
47
AtriCure
ATRC
$2.01B
$2.17M 0.2%
+64,573
New +$2.32M
ACRS icon
48
Aclaris Therapeutics
ACRS
$851M
$1.71M 0.16%
+1,647,214
New +$2.24M
CBAY
49
DELISTED
Cymabay Therapeutics
CBAY
$1.59M 0.14%
+1,077,467
New +$1.81M
QURE icon
50
uniQure
QURE
$3.15B
$1.09M 0.1%
+22,932
New +$1.32M
1
2
3

Similar funds

FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Vivo Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Vivo Capital held 57 positions worth $1.1B, down 20% from $1.37B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Vivo Capital withdrew a net $108M in Q1 2020, closing 4 positions.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, followed by Financials and Materials.

Against the trend, Vivo Capital opened a new position in Ascendis Pharma A/S worth $226M.

  • Vivo Capital's largest Q1 2020 buy was Ascendis Pharma A/S: 2,003,147 shares worth $226M.
  • Vivo Capital's ten largest holdings make up 61% of its $1.1B portfolio in Q1 2020.
  • Vivo Capital opened 53 new positions and closed 4 in Q1 2020.
  • Vivo Capital's portfolio value fell 20% quarter-over-quarter to $1.1B.

Based on Vivo Capital's 13F filing for Q1 2020, filed 15 May 2020.